Gut-ocular axis: An emerging strategy to treat ocular diseases

doi:10.12998/wjcc.124172

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 25

This Article

(2)

(3)

(0)

(1)

(25)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Cases. Sep 6, 2026; 14(25): 124172
Published online Sep 6, 2026. doi: 10.12998/wjcc.124172

Full Size Figure Download Figure

Figure 3 Therapeutic targets and specific ocular disease implications. This diagram depicts two potential therapeutic targets- modulation strategies: How prebiotics, probiotics, diet, and fecal microbiota transplantation can potentially restore microbiota diversity. Targeted ocular diseases: Linking the gut-ocular axis to specific conditions like dry eye, uveitis, glaucoma, and age-related macular degeneration. FMT: Fecal microbiota transplantation; AMD: Age-related macular degeneration; SCFAs: Short-chain fatty acids.

Citation: Paul RS, Samanta A. Gut-ocular axis: An emerging strategy to treat ocular diseases. World J Clin Cases 2026; 14(25): 124172
URL: https://www.wjgnet.com/2307-8960/full/v14/i25/124172.htm
DOI: https://dx.doi.org/10.12998/wjcc.124172

Paul RS, Samanta A. Gut-ocular axis: An emerging strategy to treat ocular diseases. World J Clin Cases 2026; 14(25): 124172 [DOI: 10.12998/wjcc.124172]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.